Fierce Biotech3d
Dexcom receives FDA warning letter over CGM manufacturing issues
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
DexCom falls 7% to $71.99 after receiving warning letter from FDA
EST DexCom (DXCM) falls 7% to $71.99 after receiving warning letter from FDADiscover the Best Stocks and Maximize Your Portfolio: See ...
DexCom Options Trading: A Deep Dive into Market Sentiment
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
DexCom Gets FDA Warning Letter After Inspections of Facilities
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
Dexcom receives FDA warning letter for two U.S. manufacturing facilities
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
Yahoo Finance4d
DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth
The announcement came after a quarter where DexCom reported a 7% increase in sales, though net income declined significantly alongside a reduction in earnings per share. During the past quarter ...
Dexcom's blood sugar monitors now sync directly with your Apple Watch — here's why it's a big deal
This means that the 1.7 million-plus global Dexcom users won't need to worry about their iPhone being with them and charged ...
The Motley Fool28d
DexCom: Revenue Up, EPS Misses Mark
Operating income (non-GAAP) decreased to $209.5 million from $242.7 million. DexCom reported mixed earnings, with revenue surpassing estimates but earnings per share falling short. DexCom ...